Keeping it in the Family
Executive SummaryResearch and Development spending at 14 privately owned, mid-sized European pharmaceutical firms averages 12% of 2001 total revenue, a contrast from the 17.7% average at their publicly traded counterparts.
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.